Atlas Trials

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

Clinical trial NCT01845259 · UNKNOWN

Trial details

NCT number
NCT01845259
Sponsor
Psychiatric Centre Rigshospitalet
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Impaired Glucose Tolerance Associated With Drugs
Start date
2013-04-01
Primary completion
2016-03-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.